Shanghai Allist Pharmaceuticals Co., Ltd.

Shanghai Stock Exchange 688578.SS

Shanghai Allist Pharmaceuticals Co., Ltd. Free Cash Flow for the year ending December 31, 2023: USD 85.46 M

Shanghai Allist Pharmaceuticals Co., Ltd. Free Cash Flow is USD 85.46 M for the year ending December 31, 2023, a 1,229.71% change year over year. Free cash flow is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.
  • Shanghai Allist Pharmaceuticals Co., Ltd. Free Cash Flow for the year ending December 31, 2022 was USD -7.57 M, a 70.50% change year over year.
  • Shanghai Allist Pharmaceuticals Co., Ltd. Free Cash Flow for the year ending December 31, 2021 was USD -25.65 M, a 41.30% change year over year.
  • Shanghai Allist Pharmaceuticals Co., Ltd. Free Cash Flow for the year ending December 31, 2020 was USD -43.69 M, a 12.75% change year over year.
  • Shanghai Allist Pharmaceuticals Co., Ltd. Free Cash Flow for the year ending December 31, 2019 was USD -50.08 M, a -158.50% change year over year.
Key data
Date Free Cash Flow Operating Cash Flow Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities
Market news
SV Wall Street
Shanghai Stock Exchange: 688578.SS

Shanghai Allist Pharmaceuticals Co., Ltd.

CEO Mr. Jinhao Du
IPO Date Dec. 2, 2020
Location China
Headquarters No. 268 Lingxiaohua Road
Employees 1,044
Sector Healthcare
Industries
Pharmaceuticals Biotechnology Clinical Trials
Description

Shanghai Allist Pharmaceuticals Co., Ltd. engages in the research and development of pharmaceutical products in China. It offers pharmaceuticals for the treatment of tumor and cancer diseases. The company was founded in 2004 and is based in Shanghai, China.

StockViz Staff

February 2, 2025

Any question? Send us an email